HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 21201567, compound → HCID 21201602, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 21201567 | HCID 21201567 | — |
| Catalyst | Platinum oxide (PtO) | HCID 82844 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 21201602 | HCID 21201602 | 66.3% |
Reaction Steps
Platinum oxide (100 mg) was added to a solution of 2-oxo-3-tert-butoxycarbonylamino-5-(2-cyclopenten-1-yl)-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine (1.8 g) in anhydrous tetrahydrofuran (20 ml), the mixture was stirred at room temperature under ambient pressure under hydrogen atmosphere for 2 hours. The reaction mixture was filtrated through a pad of Celite, the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography(ethyl acetate:n-hexane=1:2). Diisopropyl ether was added to the residue for crystallization, to thereby obtain 1.2 g of the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06239131B1 |
| Source dataset | uspto-grants-2001_05 |
| ORD ID | ord-4a4c2b37eef24263a5049dfcf7b305ae |
| Source note | uspto-grants-2001_05 |